JOSHUA CAMPBELL: Open Payments
NPI 1083109565 · SPRINGFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,242 in 122 payments from 28 companies in 2025. Trend: 2023 $663 · 2024 $1,938 · 2025 $2,242
Food & beverage: $2,242
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $396 |
| TG Therapeutics, Inc. | 19 | $213 |
| Biogen, Inc. | 9 | $195 |
| UCB, Inc. | 5 | $121 |
| Novartis Pharmaceuticals Corporation | 4 | $103 |
| GENZYME CORPORATION | 3 | $99 |
| Alexion Pharmaceuticals, Inc. | 6 | $96 |
| Neurocrine BioSciences, Inc. | 4 | $92 |
| Neurelis, Inc. | 5 | $91 |
| Lilly USA, LLC | 4 | $82 |
Products named: QULIPTA, BRIUMVI, UBRELVY, TYSABRI, ULTOMIRIS, Nayzilam, INGREZZA, SKYCLARYS.
Industry payments across IL — which companies pay providers there.
